Zio AT ECG Monitoring System vs Merlin.net

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by iRhythm Technologies, Inc.
VS
by Abbott (formerly St. Jude Medical)

AI Verdict

Tool A, the Zio AT ECG Monitoring System, is designed for continuous, AI-powered ECG monitoring using a wearable patch to diagnose arrhythmias. In contrast, Tool B, Merlin.net, is a remote monitoring platform specifically for managing data from Abbott's implanted cardiac devices. While both operate in cardiology and remote monitoring, Tool A focuses on diagnostic arrhythmia detection via an external device, whereas Tool B is for the ongoing management of patients with existing internal cardiac implants.

Choose Zio AT ECG Monitoring System if…

Choose Zio AT if you require a diagnostic solution for long-term, continuous ECG monitoring to detect and characterize arrhythmias in patients without an existing implanted cardiac device. This system is ideal for identifying symptomatic and asymptomatic cardiac events over an extended period, providing comprehensive data for initial diagnosis or when an implanted device is not yet warranted.

View Zio AT ECG Monitoring System →

Choose Merlin.net if…

Choose Merlin.net if you are managing patients who already have Abbott-manufactured implanted cardiac devices and require robust remote follow-up and data management. This platform is specifically designed for monitoring device performance, reviewing cardiac data, and coordinating patient care for those with existing pacemakers, ICDs, or other Abbott implants.

View Merlin.net →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Zio AT ECG Monitoring System Merlin.net
Pricing Contact for pricing Unknown
Deployment Cloud-based (data analytics and clinician portal) Web-based
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Zio AT ECG Monitoring System

Zio AT emphasizes patient usability with its comfortable wearable patch and the MyZio patient mobile app for symptom logging, which patients generally find less intrusive than traditional monitors. While Merlin.net offers strong clinician-focused usability, Zio AT's patient-centric design for ease of wear and interaction gives it an edge in broader usability.

Clinical Value

Tie

Both tools offer significant, yet distinct, clinical value. Zio AT excels in the diagnostic phase with its FDA-cleared deep-learned AI algorithm for continuous, long-term arrhythmia detection, providing a high diagnostic yield. Merlin.net is invaluable for the ongoing management of patients with implanted cardiac devices, enabling remote follow-up, reducing in-office visits, and facilitating timely interventions. Their contributions are complementary in the cardiology care continuum.

Pricing & Value

Tie

Neither Zio AT nor Merlin.net publicly discloses its pricing information, both requiring direct contact with the vendor. Without transparent pricing details, it is impossible to conduct a meaningful head-to-head comparison of their value propositions based on cost.

Enterprise Readiness

Merlin.net

While both tools are cloud-based, HIPAA compliant, have BAAs, and are FDA cleared, Merlin.net explicitly highlights its 'EHRDirect data transfer for seamless EHR integration (HL7 standards)'. This direct and standardized integration with existing electronic health record systems is a critical feature for enterprise adoption and operational efficiency, giving Tool B a distinct advantage in readiness for large healthcare systems.

Innovation

Zio AT ECG Monitoring System

Zio AT's core innovation lies in its wearable patch for continuous ECG recording combined with an FDA-cleared deep-learned AI algorithm (ZEUS System) for arrhythmia detection. This represents a significant technological advancement in diagnostic capabilities for cardiac arrhythmias. Merlin.net's innovations are more focused on optimizing the comprehensive management of existing implanted devices through its platform features.

Support & Docs

Tie

Both iRhythm and Abbott appear to offer comprehensive support and documentation for their respective products. iRhythm provides online resources, clinician training, customer service, and detailed manuals, while Abbott offers a dedicated support team, online training modules, technical documentation, and user guides through its portal. Based on the available information, neither tool demonstrates a clear superiority in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Zio AT ECG Monitoring System Merlin.net
Primary Device Monitored Wearable Zio AT patch Abbott implanted cardiac devices
Monitoring Purpose/Focus Continuous ECG recording for long-term arrhythmia detection Remote follow-up, device performance monitoring, and informed clinical decisions
AI Algorithm for Detection FDA-cleared deep-learned AI algorithm (ZEUS System) for arrhythmia detection Not specified
Data Transmission Method Wireless gateway for real-time data transmission Remote monitoring platform for managing data from implanted devices
Clinician Interface ZioSuiteu00ae clinician portal and mobile app Web-based interface for clinicians
Patient Engagement Features MyZiou00ae patient mobile app for symptom logging and education DirectCallu2122 integrated patient communication, SmartScheduleu2122 calendar for follow-up coordination
EHR Integration Not specified EHRDirectu2122 data transfer for seamless EHR integration (HL7 standards)

Videos

Demos, reviews, and walkthroughs featuring Zio AT ECG Monitoring System and Merlin.net.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The Zio AT ECG Monitoring System is designed for continuous ECG monitoring using a wearable patch to detect arrhythmias. In contrast, Merlin.net is a remote monitoring platform specifically for managing data from Abbott's implanted cardiac devices, such as pacemakers and implantable cardioverter defibrillators.
Zio AT's primary focus is long-term arrhythmia detection through continuous, AI-powered ECG monitoring for up to 14 days. Merlin.net's main application is remote follow-up, device performance monitoring, and data management for patients with Abbott's implanted cardiac devices.
Zio AT utilizes a wearable patch for continuous ECG recording and offers a MyZio patient mobile app for symptom logging and education. Merlin.net collects data from implanted cardiac devices and provides features like DirectCall for integrated patient communication and a SmartSchedule calendar for follow-up coordination.
Yes, the Zio AT ECG Monitoring System incorporates an FDA-cleared deep-learned AI algorithm (ZEUS System) specifically for arrhythmia detection. While Merlin.net manages cardiac information and trends, its description does not explicitly detail an AI algorithm for arrhythmia detection.
Zio AT provides comprehensive end-of-wear reports and access through its ZioSuite clinician portal and mobile app. Merlin.net offers a web-based interface for data review, EHRDirect data transfer for seamless EHR integration using HL7 standards, and DirectAlerts for patient events.
The Zio AT system offers continuous, uninterrupted ECG recording for up to 14 days. Merlin.net, on the other hand, is designed for ongoing remote follow-up and management of implanted cardiac devices, rather than a fixed duration for a wearable monitor.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.